The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers (2013)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1007/978-1-4614-6182-1_5
- Subjects: NEOPLASIAS PROSTÁTICAS; RECEPTORES ANDROGÊNICOS; CROMATINA; POLIMORFISMO
- Language: Inglês
- Imprenta:
- ISBN: 9781461461814
- Source:
- Título do periódico: Androgen-responsive genes in prostate cancer: regulation, function and clinical applications
- Volume/Número/Paginação/Ano: 348 p
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
NOUSHMEHR, Houtan et al. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers. Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. Tradução . New York: Springer, 2013. . Disponível em: https://doi.org/10.1007/978-1-4614-6182-1_5. Acesso em: 29 maio 2024. -
APA
Noushmehr, H., Coetzee, S. G., Rhie, S. K., Yan, C., & Coetzee, G. A. (2013). The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers. In Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. New York: Springer. doi:10.1007/978-1-4614-6182-1_5 -
NLM
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Coetzee GA. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers [Internet]. In: Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. New York: Springer; 2013. [citado 2024 maio 29 ] Available from: https://doi.org/10.1007/978-1-4614-6182-1_5 -
Vancouver
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Coetzee GA. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers [Internet]. In: Androgen-responsive genes in prostate cancer: regulation, function and clinical applications. New York: Springer; 2013. [citado 2024 maio 29 ] Available from: https://doi.org/10.1007/978-1-4614-6182-1_5 - Charting epigenomic signatures in CpG island methylator phenotype (CIMP) tumors
- Whole genome DNA is distinctly methylated in functioning and non-functioning pituitary macroadenomas
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- The cancer genome atlas pan-cancer analysis project
- Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer
- Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
- Src as a novel therapeutic target for endometriosis
- Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon
- Methylation-based liquid biopsy of meningioma primary and recurrent samples
- Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer
Informações sobre o DOI: 10.1007/978-1-4614-6182-1_5 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
